A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
Public ClinicalTrials.gov record NCT05757102. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, 24-week, Randomized, Double-blind, Parallel-group Bayesian Dynamic Borrowing Study Comparing the Efficacy, Safety, Tolerability and Pharmacokinetics of FF/UMEC/VI With FF/VI in 12-17-year-old Participants With Inadequately Controlled Asthma on Stable Maintenance Therapy With ICS/LABA
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to evaluate the effects of Fluticasone Furoate (FF)/ Umeclidinium (UMEC)/ Vilanterol (VI) on lung function compared with FF/VI after 24 weeks of treatment.
Study identification
- NCT ID
- NCT05757102
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 292 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 24, 2023
- Primary completion
- Jan 21, 2027
- Completion
- Jan 27, 2027
- Last update posted
- Jul 15, 2026
2023 – 2027
United States locations
- U.S. sites
- 26
- U.S. states
- 15
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Investigational Site | Birmingham | Alabama | 35244 | Recruiting |
| GSK Investigational Site | Mobile | Alabama | 36608 | Recruiting |
| GSK Investigational Site | Paradise Valley | Arizona | 85253 | Recruiting |
| GSK Investigational Site | Bakersfield | California | 93301 | Recruiting |
| GSK Investigational Site | Mission Viejo | California | 92691 | Recruiting |
| GSK Investigational Site | Rolling Hills Estates | California | 90274 | Completed |
| GSK Investigational Site | Colorado Springs | Colorado | 80909 | Recruiting |
| GSK Investigational Site | Aventura | Florida | 33180 | Completed |
| GSK Investigational Site | Miami | Florida | 33165 | Recruiting |
| GSK Investigational Site | Miami | Florida | 33173 | Completed |
| GSK Investigational Site | Miami | Florida | 33174 | Recruiting |
| GSK Investigational Site | Savannah | Georgia | 31406 | Completed |
| GSK Investigational Site | Normal | Illinois | 61761 | Recruiting |
| GSK Investigational Site | Owensboro | Kentucky | 42301 | Recruiting |
| GSK Investigational Site | Columbia | Missouri | 65203 | Completed |
| GSK Investigational Site | Missoula | Montana | 59808 | Recruiting |
| GSK Investigational Site | The Bronx | New York | 10461 | Recruiting |
| GSK Investigational Site | Cincinnati | Ohio | 45229 | Recruiting |
| GSK Investigational Site | Cleveland | Ohio | 44106 | Recruiting |
| GSK Investigational Site | Dayton | Ohio | 45404 | Completed |
| GSK Investigational Site | Oklahoma City | Oklahoma | 73120 | Recruiting |
| GSK Investigational Site | Charleston | South Carolina | 29420 | Recruiting |
| GSK Investigational Site | Dallas | Texas | 75225-6301 | Recruiting |
| GSK Investigational Site | Kerrville | Texas | 78028 | Recruiting |
| GSK Investigational Site | Plano | Texas | 75034 | Completed |
| GSK Investigational Site | Waco | Texas | 76712 | Completed |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.
Recently updated Asthma trials
Other public records listing Asthma. Sorted by last update posted; newest first. Not a recommendation.
- NCT07792395: Ginger's Therapeutic Potential in Asthma Not yet recruiting
- NCT07792330: Asthma Lung Sounds With Wearable Stethoscope Not yet recruiting
- NCT07671001: A Study of Depemokimab in Participants of 6 to 11 Years of Age Recruiting
- NCT07772921: A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma Not yet recruiting
- NCT07444567: Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment Recruiting
- NCT01449409: Reduce IDentified UNcontrolled Asthma Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05757102, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 15, 2026 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05757102 live on ClinicalTrials.gov.